4//SEC Filing
Baker Mark Robert 4
Accession 0001447348-13-000004
CIK 0000835887other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:24 PM ET
Size
7.3 KB
Accession
0001447348-13-000004
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2013-02-27$2.71/sh+500$1,355→ 159,729 total - Purchase
Common Stock
2013-02-27$2.72/sh+535$1,455→ 160,264 total - Purchase
Common Stock
2013-02-27$2.75/sh+227$624→ 160,491 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001331438
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:24 PM ET
- Size
- 7.3 KB